Trial intelligence / Profile preview

Duloxetine Plus Exercise in Veterans With Knee Osteoarthritis, Pain, and Depression

NCT07649291Phase 2Not yet recruiting

Sponsor
VA Office of Research & Development
Start
Mar 2027
Primary completion
Sep 2031
Countries
1
01

Overview

A Phase 2 trial of duloxetine in knee osteoarthritis (OA), major depressive disorder (MDD), pain, sponsored by VA Office of Research & Development. Planned start Mar 2027; status: not yet recruiting.

02

Drugs

duloxetine
03

Conditions

knee osteoarthritis (OA)major depressive disorder (MDD)pain

Beyond the preview

Go deeper on NCT07649291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07649291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call